Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: S&P Capital IQ Factual Report
$161.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Myriad Genetics Inc completes acquisition of Crescendo Bioscience, Inc - Form 8-K


Friday, 28 Feb 2014 04:47pm EST 

Myriad Genetics Inc:Completes the acquisition of privately-held Crescendo Bioscience, Inc.Acquired Crescendo by means of a reverse triangular merger in which Crescendo survived the merger as the surviving corporation and a wholly-owned subsidiary of Myriad.The surviving corporation will operate under the name Crescendo Bioscience, Inc.Paid an aggregate cash purchase price to the security holders of Crescendo of $245 mln. 

Related Company News

Company Quote

35.55
-0.645 -1.78%
26 Mar 2015